Database : MEDLINE
Search on : Mesonephroma [Words]
References found : 1089 [refine]
Displaying: 1 .. 10   in format [Detailed]

page 1 of 109 go to page                         

  1 / 1089 MEDLINE  
              next record last record
select
to print
Photocopy

[PMID]: 27172762
[Au] Autor:Yeo MK; Choi SY; Kim M; Kim KH; Suh KS
[Ti] Title:Malignant mesonephric tumor of the cervix with an initial manifestation as pulmonary metastasis: case report and review of the literature.
[So] Source:Eur J Gynaecol Oncol;37(2):270-7, 2016.
[Is] ISSN:0392-2936
[Cp] Country of publication:Italy
[La] Language:eng
[Ab] Abstract:Malignant mesonephric tumor (MMT) is a relatively uncommon malignancy of the female genital tract. The diagnosis of metastatic MMT is difficult because cytological, pathological, immunohistochemical characteristics of MMT are under-recognized. The authors present a 55-year-old female with metastatic pulmonary nodules. The bronchial washing cytology revealed three dimensional clusters of bland epithelial cells with slight nuclear grooves. A corresponding lung histology had ductal or tubular clusters of epithelial cells with intraglandular eosinophilic materials. These epithelial cells were positive for immunohistochemical stain of CD10, suggesting metastasis from MMT. The cervical smear showed clusters of bland, gland-forming epithelial cells with intraglandular eosinophilic materials. On histologic examination, mesonephric adenocarcinoma with papillary and solid proliferation was identified in the uterine cervix. A review of the literature for 72 cases of MMT is also included. Clinical and cytopathological features of MMT are herein made available.
[Mh] MeSH terms primary: Lung Neoplasms/secondary
Mesonephroma/secondary
Multiple Pulmonary Nodules/secondary
Uterine Cervical Neoplasms/pathology
[Mh] MeSH terms secundary: Biopsy
Bronchoalveolar Lavage Fluid/cytology
Female
Humans
Lung Neoplasms/diagnosis
Mesonephroma/diagnosis
Middle Aged
Multimodal Imaging
Positron-Emission Tomography
Tomography, X-Ray Computed
[Pt] Publication type:CASE REPORTS; JOURNAL ARTICLE; RESEARCH SUPPORT, NON-U.S. GOV'T; REVIEW
[Em] Entry month:1607
[Cu] Class update date: 160513
[Lr] Last revision date:160513
[Js] Journal subset:IM
[Da] Date of entry for processing:160514
[St] Status:MEDLINE

  2 / 1089 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy

[PMID]: 27147080
[Au] Autor:Kir G; Seneldir H; Kiran G
[Ad] Address:a Pathology Department , Umraniye Education & Research Hospital , Istanbul , Turkey and.
[Ti] Title:A case of mesonephric adenocarcinoma of the uterine cervix mimicking an endometrial clear cell carcinoma in the curettage specimen.
[So] Source:J Obstet Gynaecol;36(6):827-829, 2016 Aug.
[Is] ISSN:1364-6893
[Cp] Country of publication:England
[La] Language:eng
[Mh] MeSH terms primary: Adenocarcinoma/diagnosis
Mesonephroma/diagnosis
Uterine Cervical Neoplasms/diagnosis
[Mh] MeSH terms secundary: Adenocarcinoma/pathology
Adenocarcinoma, Clear Cell/diagnosis
Diagnosis, Differential
Dilatation and Curettage
Endometrial Neoplasms/diagnosis
Female
Humans
Mesonephroma/pathology
Middle Aged
Uterine Cervical Neoplasms/pathology
[Pt] Publication type:CASE REPORTS; LETTER
[Em] Entry month:1706
[Cu] Class update date: 170622
[Lr] Last revision date:170622
[Js] Journal subset:IM
[Da] Date of entry for processing:160506
[St] Status:MEDLINE

  3 / 1089 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
Full text

[PMID]: 26166228
[Au] Autor:Ditto A; Martinelli F; Bogani G; Gasparri ML; Donato VD; Paolini B; Carcangiu ML; Lorusso D; Raspagliesi F
[Ad] Address:Department of Gynecologic Oncology, IRCCS National Cancer Institute, Milan - Italy.
[Ti] Title:Bulky mesonephric adenocarcinoma of the uterine cervix treated with neoadjuvant chemotherapy and radical surgery: report of the first case.
[So] Source:Tumori;102(Suppl. 2), 2016 Nov 11.
[Is] ISSN:2038-2529
[Cp] Country of publication:Italy
[La] Language:eng
[Ab] Abstract:AIMS AND BACKGROUND: Malignant mesonephric adenocarcinoma of the uterine cervix is a rare occurrence with few cases described in the literature. Although surgery seems to be effective in the treatment of early-stage tumor, no cases describing outcomes of locally advanced stage are available. METHODS: We report the first case of a patient with International Federation of Obstetrics and Gynecologists stage IIB mesonephric adenocarcinoma undergoing neoadjuvant chemotherapy and radical surgery. CONCLUSIONS: Despite the inherent limitation of a single description of a case, our experience supports the utilization of neoadjuvant chemotherapy in patients with malignant mesonephric adenocarcinoma of the uterine cervix. Further prospective multi-institutional studies are needed.
[Mh] MeSH terms primary: Adenocarcinoma/diagnosis
Adenocarcinoma/therapy
Mesonephroma/diagnosis
Mesonephroma/therapy
Uterine Cervical Neoplasms/diagnosis
Uterine Cervical Neoplasms/therapy
[Mh] MeSH terms secundary: Biopsy
Combined Modality Therapy
Female
Humans
Magnetic Resonance Imaging
Middle Aged
Neoplasm Grading
Neoplasm Staging
[Pt] Publication type:CASE REPORTS; JOURNAL ARTICLE
[Em] Entry month:1702
[Cu] Class update date: 170206
[Lr] Last revision date:170206
[Js] Journal subset:IM
[Da] Date of entry for processing:150714
[St] Status:MEDLINE
[do] DOI:10.5301/tj.5000386

  4 / 1089 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy

[PMID]: 26338754
[Au] Autor:Tekin L; Yazici A; Akbaba E; Akin MN
[Ad] Address:Department of Pathology, Training and Research Hospital of Mugla Sitki Kocman University, Mugla, Turkey.
[Ti] Title:Mesonephric adenocarcinoma of the uterine cervix: A case report and review of the literature.
[So] Source:J Pak Med Assoc;65(9):1016-7, 2015 Sep.
[Is] ISSN:0030-9982
[Cp] Country of publication:Pakistan
[La] Language:eng
[Ab] Abstract:Mesonephric adenocarcinoma is a rare neoplasm of uterine cervix. It originates from the mesonephric ductus remnant or mesonephric hyperplasia area. There have been few such cases reported. Our case was 64 years of age and her tumour held the whole endocervical wall. It was around 5cm in diameter, and had exophytic component as well. Bilateral pelvic and paraaortic lymph nodes were negative for metastasis.
[Mh] MeSH terms primary: Adenocarcinoma/pathology
Mesonephroma/pathology
Uterine Cervical Neoplasms/pathology
[Mh] MeSH terms secundary: Diagnosis, Differential
Female
Humans
Middle Aged
[Pt] Publication type:CASE REPORTS; JOURNAL ARTICLE; REVIEW
[Em] Entry month:1512
[Cu] Class update date: 150904
[Lr] Last revision date:150904
[Js] Journal subset:IM
[Da] Date of entry for processing:150905
[St] Status:MEDLINE

  5 / 1089 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
Full text

[PMID]: 26336887
[Au] Autor:Mirkovic J; Sholl LM; Garcia E; Lindeman N; MacConaill L; Hirsch M; Dal Cin P; Gorman M; Barletta JA; Nucci MR; McCluggage WG; Howitt BE
[Ad] Address:Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.
[Ti] Title:Targeted genomic profiling reveals recurrent KRAS mutations and gain of chromosome 1q in mesonephric carcinomas of the female genital tract.
[So] Source:Mod Pathol;28(11):1504-14, 2015 Nov.
[Is] ISSN:1530-0285
[Cp] Country of publication:United States
[La] Language:eng
[Ab] Abstract:Mesonephric carcinoma is a rare form of gynecologic cancer derived from mesonephric remnants usually located in the lateral wall of the uterine cervix. An analogous tumor occurs in the adnexa, female adnexal tumor of probable Wolffian origin. The pathogenesis and molecular events in mesonephric carcinoma are not known. The aim of this study was to examine the molecular alterations in mesonephric carcinoma to identify driver mutations and therapeutically targetable mutations. This study consisted of 19 tumors from 17 patients: 18 mesonephric carcinomas (15 primary tumors and three metastatic tumors) and 1 female adnexal tumor of probable Wolffian origin. In two patients, both primary and metastatic tumors were available. Genomic DNA was isolated and targeted next-generation sequencing was performed to detect mutations, copy number variations, and structural variants by surveying full exonic regions of 300 cancer genes and 113 selected intronic regions across 35 genes. Fluorescence in situ hybridization (FISH) for 1p and 1q was performed in two cases. Eighty-one percent (13/16) of mesonephric carcinomas had either a KRAS (n=12) or NRAS (n=1) mutation. Mutations in chromatin remodeling genes (ARID1A, ARID1B, or SMARCA4) were present in 62% of mesonephric carcinomas. All mesonephric carcinomas lacked mutations in PIK3CA and PTEN. The most common copy number alteration was 1q gain, found in 12 (75%) mesonephric carcinomas; this was confirmed by FISH in two cases. Mesonephric carcinoma is characterized by molecular alterations that differ from those of more common variants of cervical and endometrial adenocarcinoma, which harbor KRAS/NRAS mutations in 7% and 25% of cases, respectively. KRAS/NRAS mutations are common in mesonephric carcinoma and are often accompanied by gain of 1q and mutations in chromatin remodeling genes. Targeting inhibitors of the RAS/MAPK pathway may be useful in the treatment of mesonephric carcinoma.
[Mh] MeSH terms primary: Chromosomes, Human, Pair 1/genetics
Mesonephroma/genetics
Proto-Oncogene Proteins p21(ras)/genetics
Uterine Cervical Neoplasms/genetics
Uterine Neoplasms/genetics
[Mh] MeSH terms secundary: Adult
Aged
Aged, 80 and over
Female
GTP Phosphohydrolases/genetics
Gene Expression Profiling/methods
Humans
In Situ Hybridization, Fluorescence
Membrane Proteins/genetics
Middle Aged
[Pt] Publication type:JOURNAL ARTICLE; RESEARCH SUPPORT, NON-U.S. GOV'T
[Nm] Name of substance:0 (KRAS protein, human); 0 (Membrane Proteins); EC 3.6.1.- (GTP Phosphohydrolases); EC 3.6.1.- (NRAS protein, human); EC 3.6.5.2 (Proto-Oncogene Proteins p21(ras))
[Em] Entry month:1608
[Cu] Class update date: 170220
[Lr] Last revision date:170220
[Js] Journal subset:IM
[Da] Date of entry for processing:150905
[St] Status:MEDLINE
[do] DOI:10.1038/modpathol.2015.103

  6 / 1089 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
PubMed Central Full text
Full text

[PMID]: 26327963
[Au] Autor:Amal B; Hind el F; Hanane S; Hayat R; Kaoutar M; Abdelaziz B; Taoufik H; Affaf A
[Ad] Address:Service d'Anatomie Pathologique, CHU Hassan II, Fès, Maroc.
[Ti] Title:Une tumeur du vagin à ne pas méconnaitre, l'adénocarcinome mésonephrique: à propos d'un cas et revue de la literature. [A tumor of the vagina not to overlook, the mesonephric adenocarcinoma: about a case report and review of literature].
[So] Source:Pan Afr Med J;21:126, 2015.
[Is] ISSN:1937-8688
[Cp] Country of publication:Uganda
[La] Language:fre
[Mh] MeSH terms primary: Adenocarcinoma/diagnosis
Mesonephroma/diagnosis
Vaginal Neoplasms/diagnosis
[Mh] MeSH terms secundary: Adenocarcinoma/pathology
Adenocarcinoma/therapy
Female
Humans
Keratins/metabolism
Mesonephroma/pathology
Mesonephroma/therapy
Middle Aged
Neprilysin/metabolism
Vaginal Neoplasms/pathology
Vaginal Neoplasms/therapy
[Pt] Publication type:CASE REPORTS; JOURNAL ARTICLE; REVIEW
[Nm] Name of substance:68238-35-7 (Keratins); EC 3.4.24.11 (Neprilysin)
[Em] Entry month:1606
[Cu] Class update date: 150905
[Lr] Last revision date:150905
[Js] Journal subset:IM
[Da] Date of entry for processing:150902
[St] Status:MEDLINE
[do] DOI:10.11604/pamj.2015.21.126.5754

  7 / 1089 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
Full text

[PMID]: 25395492
[Au] Autor:Young RH
[Ad] Address:Massachusetts General Hospital, Boston, MA, USA Harvard Medical School, Boston, MA, USA rhyoung@partners.org.
[Ti] Title:The yolk sac tumor: reflections on a remarkable neoplasm and two of the many intrigued by it-Gunnar Teilum and Aleksander Talerman-and the bond it formed between them.
[So] Source:Int J Surg Pathol;22(8):677-87, 2014 Dec.
[Is] ISSN:1940-2465
[Cp] Country of publication:United States
[La] Language:eng
[Ab] Abstract:One of the most remarkable of human neoplasms, the yolk sac tumor, is reviewed, emphasizing its histologic diversity and differential diagnosis, occurrence at many sites, and the shared passion for this unique neoplasm of Dr Gunnar Teilum (who deserves almost all credit for delineation of the nature of the tumor and its features) and Dr Aleksander Talerman (who made his own contribution to our knowledge of it) and the friendship it helped forge between these 2 distinguished pathologists. In a unique series of articles, beginning in the early 1940s, Teilum delineated the distinctive features of the neoplasm and recognized that it was 1 of 2 initially included as "mesonephroma ovarii" by Dr Walter Schiller in 1939 (the second we now know as clear cell carcinoma). Teilum named the tumor "endodermal sinus tumor" because it came to his attention that papillary formations common in the yolk sac tumor resembled the endodermal sinuses of the rat placenta. He focused on the histogenesis of the tumor and its morphologic features culminating in a classic paper in Cancer in 1959. Although Teilum and others recognized that yolk sac tumor could be a component of mixed germ cell tumors, Talerman was one of the first to emphasize that, particularly in the testis, it was common to see yolk sac tumor as a component of a mixed germ cell tumor. Teilum, working in Copenhagen, and Talerman, when the former was alive, working in Rotterdam, developed a warm friendship in part due to their great interest in the yolk sac tumor, although it also extended to other areas of gonadal neoplasia and indeed beyond the boundaries of medicine when they shared time together. The typical histologic features of the yolk sac tumor are the reticular-microcystic patterns Teilum described, but various other patterns, including solid and even rarer ones such as glandular and hepatoid, are now well known. There are some interesting variations in the age distribution of this tumor at various sites: for example, vaginal examples are almost restricted to children under 2 years of age; those of the testis that are pure also occur mostly in young boys (average age about 20 months) but are occasionally seen in later years; ovarian examples peak at about 19 years of age; mediastinal forms are mostly restricted to young adult males. Brief consideration is also given to the occurrence of this tumor at well-known extragonadal sites such as retroperitoneum, mediastinum, and pineal as well as more exotic locations. Note is made of the recently emphasized occurrence of the yolk sac tumor on the background of a somatic neoplasm, most often endometrioid carcinoma of the ovary. Given the wide ranging and fascinating clinical and pathologic aspects of the neoplasm, it is no surprise that it continues to be a source of great interest to any pathologist who sees one or more examples, and we are indebted to Dr Teilum for his monumental studies and to Dr Talerman for his own contributions.
[Mh] MeSH terms primary: Adenocarcinoma, Clear Cell/pathology
Endodermal Sinus Tumor/pathology
Ovarian Neoplasms/pathology
Testicular Neoplasms/pathology
[Mh] MeSH terms secundary: Diagnosis, Differential
Female
Humans
Male
[Pt] Publication type:JOURNAL ARTICLE; REVIEW
[Em] Entry month:1507
[Cu] Class update date: 141204
[Lr] Last revision date:141204
[Js] Journal subset:IM
[Da] Date of entry for processing:141115
[St] Status:MEDLINE
[do] DOI:10.1177/1066896914558265

  8 / 1089 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
Full text

[PMID]: 25272303
[Au] Autor:Roma AA
[Ad] Address:Department of Anatomic Pathology, Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland Ohio.
[Ti] Title:Mesonephric carcinosarcoma involving uterine cervix and vagina: report of 2 cases with immunohistochemical positivity For PAX2, PAX8, and GATA-3.
[So] Source:Int J Gynecol Pathol;33(6):624-9, 2014 Nov.
[Is] ISSN:1538-7151
[Cp] Country of publication:United States
[La] Language:eng
[Ab] Abstract:Mesonephric carcinomas are rare tumors predominantly arising in the uterine cervix from mesonephric remnants. Although the tumor has classic morphologic features, some cases can mimic Müllerian adenocarcinoma and be misdiagnosed, especially those with significant ductal pattern. Moreover, there is an overlap in immunohistochemical results with endometrial and endocervical carcinomas. In this study, we report 2 cases of mesonephric carcinosarcoma, originally diagnosed as Müllerian carcinomas, 1 presenting in the vagina; review immunohistochemical results including positivity for GATA-3, not previously reported and comment on the proposed panel of PAX8, p16, and estrogen receptors as discriminators of Müllerian adenocarcinoma (endocervical or endometrial) versus mesonephric carcinoma.
[Mh] MeSH terms primary: Biomarkers, Tumor/analysis
Carcinosarcoma/pathology
Mesonephroma/pathology
Uterine Cervical Neoplasms/pathology
Vaginal Neoplasms/pathology
[Mh] MeSH terms secundary: Aged
Female
GATA3 Transcription Factor/analysis
GATA3 Transcription Factor/biosynthesis
Humans
Immunohistochemistry
Middle Aged
PAX2 Transcription Factor/analysis
PAX2 Transcription Factor/biosynthesis
PAX8 Transcription Factor
Paired Box Transcription Factors/analysis
Paired Box Transcription Factors/biosynthesis
[Pt] Publication type:CASE REPORTS; JOURNAL ARTICLE
[Nm] Name of substance:0 (Biomarkers, Tumor); 0 (GATA3 Transcription Factor); 0 (GATA3 protein, human); 0 (PAX2 Transcription Factor); 0 (PAX2 protein, human); 0 (PAX8 Transcription Factor); 0 (PAX8 protein, human); 0 (Paired Box Transcription Factors)
[Em] Entry month:1506
[Cu] Class update date: 161125
[Lr] Last revision date:161125
[Js] Journal subset:IM
[Da] Date of entry for processing:141002
[St] Status:MEDLINE
[do] DOI:10.1097/PGP.0000000000000088

  9 / 1089 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
Full text

[PMID]: 25272301
[Au] Autor:Goyal A; Yang B
[Ad] Address:Cleveland Clinic, Cleveland, Ohio.
[Ti] Title:Differential patterns of PAX8, p16, and ER immunostains in mesonephric lesions and adenocarcinomas of the cervix.
[So] Source:Int J Gynecol Pathol;33(6):613-9, 2014 Nov.
[Is] ISSN:1538-7151
[Cp] Country of publication:United States
[La] Language:eng
[Ab] Abstract:Mesonephric remnants, usually located deep in the lateral cervical wall, may become hyperplastic resulting in a florid proliferation. These can be misinterpreted as malignant and confused with endocervical adenocarcinomas. Recent data have shown that PAX2 is diffusely expressed in mesonephric remnants and hyperplasias. PAX8 is a related transcription protein that is expressed in tissues of müllerian and wolffian origin. In this study, we have investigated the utility of an immunohistochemical panel comprising of PAX8, estrogen receptor (ER), and p16 in the differential diagnosis between mesonephric proliferations and cervical adenocarcinomas. A database search was conducted for cases of mesonephric remnants/hyperplasia/carcinoma of cervix and invasive cervical adenocarcinomas. Immunohistochemical stains for PAX8, ER, and p16 were performed using the avidin-biotin peroxidase technique on the most representative tissue. The search yielded 28 cases of mesonephric proliferations of cervix (15 mesonephric remnants, 12 mesonephric hyperplasias, and 1 mesonephric adenocarcinoma) and 16 cases of cervical adenocarcinomas (15 usual type and 1 adenoma malignum). Immunohistochemically, all the mesonephric proliferations, regardless of being benign or malignant, displayed a consistent staining pattern-diffusely and strongly positive for PAX8, negative for ER, and patchy cytoplasmic staining for p16. The usual type cervical adenocarcinomas exhibited a variable staining pattern with PAX8 and ER but all were strongly and diffusely positive for p16. The case of adenoma malignum was PAX8 positive, ER negative, and showed weak and patchy staining with p16. Our study suggests that a panel of immunohistochemical stains composed of PAX8, p16, and ER is useful in the distinction between mesonephric proliferations and cervical adenocarcinomas.
[Mh] MeSH terms primary: Adenocarcinoma/diagnosis
Biomarkers, Tumor/analysis
Mesonephroma/diagnosis
Uterine Cervical Neoplasms/diagnosis
[Mh] MeSH terms secundary: Cyclin-Dependent Kinase Inhibitor p16/analysis
Cyclin-Dependent Kinase Inhibitor p16/biosynthesis
Diagnosis, Differential
Female
Humans
Immunohistochemistry
PAX8 Transcription Factor
Paired Box Transcription Factors/analysis
Paired Box Transcription Factors/biosynthesis
Receptors, Estrogen/analysis
Receptors, Estrogen/biosynthesis
[Pt] Publication type:JOURNAL ARTICLE
[Nm] Name of substance:0 (Biomarkers, Tumor); 0 (Cyclin-Dependent Kinase Inhibitor p16); 0 (PAX8 Transcription Factor); 0 (PAX8 protein, human); 0 (Paired Box Transcription Factors); 0 (Receptors, Estrogen)
[Em] Entry month:1506
[Cu] Class update date: 161125
[Lr] Last revision date:161125
[Js] Journal subset:IM
[Da] Date of entry for processing:141002
[St] Status:MEDLINE
[do] DOI:10.1097/PGP.0000000000000102

  10 / 1089 MEDLINE  
              first record previous record
select
to print
Photocopy
PubMed Central Full text

[PMID]: 24696739
[Au] Autor:Tseng CE; Chen CH; Chen SJ; Chi CL
[Ad] Address:Department of Pathology, Buddhist Dalin Tzu Chi Hospital Chiayi, Taiwan ; School of Medicine, Tzu Chi University Hualien, Taiwan.
[Ti] Title:Tumor rupture as an initial manifestation of malignant mesonephric mixed tumor: a case report and review of the literature.
[So] Source:Int J Clin Exp Pathol;7(3):1212-7, 2014.
[Is] ISSN:1936-2625
[Cp] Country of publication:United States
[La] Language:eng
[Ab] Abstract:Malignant mesonephric mixed tumor (MMMT), or mesonephric carcinosarcoma, is a rare tumor with malignant epithelial and mesenchymal components, and is found mostly in the uterine cervix. While diagnosed at the early stage in most cases, MMMT can have an aggressive course. The clinical significance of the presence of sarcomatous components remains unsettled. We report a case of MMMT of the uterine cervix in a patient who presented with tumor rupture, instead of the common presentation, vaginal bleeding. This unusual presentation has not been reported in the literature. It implies that MMMT may progress rapidly without any prodrome and pose a surgical emergency. Unlike most cervical adenocarcinomas, both mesonephric adenocarcinoma and MMMT are not related to human papilloma virus (HPV) infection. Because mesonephric neoplasms have a different etiology, their prevention, screening, and treatment should be further investigated. Thirteen cases of MMMT reported in the literature are also reviewed.
[Mh] MeSH terms primary: Carcinosarcoma/pathology
Mesonephroma/pathology
Uterine Cervical Neoplasms/pathology
[Mh] MeSH terms secundary: Carcinosarcoma/epidemiology
Comorbidity
Diabetes Mellitus/epidemiology
Female
Humans
Hypertension/epidemiology
Mesonephroma/epidemiology
Middle Aged
Rupture
Uterine Cervical Neoplasms/epidemiology
[Pt] Publication type:CASE REPORTS; JOURNAL ARTICLE; REVIEW
[Em] Entry month:1412
[Cu] Class update date: 170220
[Lr] Last revision date:170220
[Js] Journal subset:IM
[Da] Date of entry for processing:140404
[St] Status:MEDLINE


page 1 of 109 go to page                         
   


Refine the search
  Database : MEDLINE Advanced form   

    Search in field  
1  
2
3
 
           



Search engine: iAH v2.6 powered by WWWISIS

BIREME/PAHO/WHO - Latin American and Caribbean Center on Health Sciences Information